"Why is BPA presenting this as new news if it was already disclosed?"
Maybe they thought no one was listening to the ARCH Small Cap Investment Conference on September 6, 2007 :)
A more serious explanation could be that they did not give the hole story (big safety study - cardiovascular events driven study of between 2,400 and 3,100 women exposed to LibiGel or placebo for 12 months and 4 years follow up) at the ARCH Conference (I didn't listen to the conf, just got the update by email).
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.